WASHINGTON - December 5, 2019 - (Newswire.com) - Washington, D.C.-based POMS Corporation announces the next major release of POMSnet, R500.3. POMSnet R500.3 is an industry-leading, cloud-enabled, HTML5 manufacturing execution system. This release provides enhanced user experience by leveraging HTML5 technologies for the most comprehensive, commercial, off-the-shelf (COTS) MES product available to the life sciences industry. POMSnet MES enables life science manufacturers (i.e., pharma, biotech, medical device, cell/gene therapy) to implement regulatory-compliant, paperless manufacturing workflows for batch records and product release. POMSnet R500.3 includes a user interface style update with responsive actions, including touch screen enabled hand gestures, zooming, and finger scrolling. Browser compatibility is greatly increased and now allows HTML5-enabled browser selection to run the web-based application. Mobile device delivery and responsive technology fit POMSnet R500.3 onto any mobile device screen.
In addition to the full HTML5 update of the product, POMS has also added other significant features and enhancements such as the following:
Life science manufacturers are regulated by regulatory authorities and current good manufacturing practices cGMP in the production process of pharmaceutical and biotech medicines and required to follow safety procedures. Companies have traditionally sought paper forms to document the production process recipe and specifications followed during manufacturing. With POMSnet R500.3 the manufacturing workflow can be implemented, monitored, and controlled by the manufacturing execution system to ensure regulatory guidelines are followed, best practices are implemented, and cGMP is enforced.
POMS Corporation, based out of Washington, D.C., is an MES software provider that counts five of the world's 10 largest pharmaceutical companies among its clients.
"Short term, our goal is to get this technology out in front of our customers so they can recognize the benefits quickly," said Patrick Nazzaro, General Manager at POMS. "Longer term, the technology offers us the capability to do more rapid agile development and release the extensive, feature-rich functionality the industry demands."
What pharmaceutical experts are saying about POMSnet R500.3 on LinkedIn
POMSnet R500.3 release is available now by contacting POMS Corporation.
About POMS Corporation
A Washington, D.C.-based provider of Manufacturing Execution System software for regulated life science companies. POMS provides web-based and cloud-based MES solutions for life science manufacturers ensuring FDA compliance and 21 CFR Part 11 electronic signatures for electronic batch records. POMS Corporation is a company in the Perseus Operating Group with the parent company Constellation Software Inc. headquartered in Toronto, Canada, and traded on the Toronto Stock exchange with $3.1 billion revenue and 16,000 employees worldwide.
Press Release Service by Newswire.com
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and have questions or removal requests please contact firstname.lastname@example.org